Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 3, 2016
Reporting Period: Third fiscal quarter ended September 30, 2016
This filing serves as a notification that the company issued a press release announcing its third-quarter 2016 financial results. The detailed results are contained in Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The provided text is a cover document for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the announcement of the third-quarter results.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The company expressly disclaims any obligation to release publicly any updates or changes in expectations, events, conditions, or circumstances on which forward-looking statements are based.
- Legal Status: Information in this report is furnished pursuant to Item 2.02 and is not deemed "filed" for purposes of Section 18 of the Exchange Act. It shall not be incorporated by reference into other filings under the Securities Act or Exchange Act.
- Website Availability: The text notes that the press release is available on the company website but reserves the right to discontinue that availability at any time.
Investor Verification Checklist
- Verify the specific revenue, net income, and cash flow figures in the full text of the press release (Exhibit 99.1) referenced in this filing.
- Confirm the company's current liquidity position and debt levels, as these are not detailed in the 8-K cover text.
- Review the full press release for any updated guidance or management commentary regarding the third quarter.
- Note the explicit disclaimer regarding the company's obligation to update forward-looking statements.